TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Total Assets

Annual figures by fiscal year, from SEC filings.

2009: $481.38M2010: $393.26M2011: $281.92M2012: $287.52M2013: $420.53M2014: $1.08B2015: $1.39B2016: $1.26B2017: $1.99B2018: $1.57B2019: $2.40B2020: $3.41B2021: $3.64B2022: $3.55B2023: $3.83B2024: $4.24B2025: $4.97B$4.97B
2009Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$4.97B+17.1%
2024$4.24B+10.7%
2023$3.83B+8.0%
2022$3.55B-2.7%
2021$3.64B+6.9%
2020$3.41B+42.2%
2019$2.40B+52.1%
2018$1.57B-21.1%
2017$1.99B+58.0%
2016$1.26B-8.9%
2015$1.39B+28.4%
2014$1.08B+156.7%
2013$420.53M+46.3%
2012$287.52M+2.0%
2011$281.92M-28.3%
2010$393.26M-18.3%
2009$481.38M—